5tmg: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Description: Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Lane, W]] | |||
[[Category: Okada, K]] | [[Category: Okada, K]] | ||
[[Category: Snell, G.P]] | [[Category: Snell, G.P]] | ||
[[Category: Sang, B.C]] | [[Category: Sang, B.C]] | ||
[[Category: Hideyuki, O]] | [[Category: Hideyuki, O]] | ||
[[Category: Behnke, C.A]] | [[Category: Behnke, C.A]] |